Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Black Women's Perspectives on Seeking Social Support for Physical Activity: A Qualitative Study.

Behavioral medicine (Washington, D.C.)·2026
Same author

Predictors of Self-Care Behaviours Among Patients With Chronic Disease: A Multicountry Survey.

Nursing research and practice·2026
Same author

Plant-based diet quality and cardiometabolic biomarkers in pregnant U.S. women.

Nutrition and health·2026
Same author

Social and Environmental Determinants of Stroke Functional Outcome and Strategies to Reduce Inequities: A Scientific Statement From the American Heart Association.

Stroke·2026
Same author

A life course approach to cardiovascular disease prevention.

European journal of cardiovascular nursing·2026
Same author

Community-Based and Public Health Initiatives Drive Cardiovascular Disease Prevention.

European journal of cardiovascular nursing·2026
Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026
Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
関連記事をすべて見る

関連する実験動画

Updated: May 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

異常な血脂の管理:協力的なアプローチ

Barbara Fletcher, Kathy Berra, Phil Ades

    Circulation
    |November 16, 2005
    PubMed
    まとめ
    この要約は機械生成です。

    異常な血液脂質 (ABL) の治療には,さまざまな専門家が関与する多学科的なアプローチが必要です. この共同ケアモデルは,患者の治療結果を改善し,心血管および脳血管疾患の発生を減少させます.

    さらに関連する動画

    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    3.7K
    Multidisciplinary Approach to Obesity Management: A Case Report
    05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    1.5K

    関連する実験動画

    Last Updated: May 3, 2026

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    14.8K
    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    3.7K
    Multidisciplinary Approach to Obesity Management: A Case Report
    05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    1.5K

    科学分野:

    • 心臓病学 心臓病学
    • 予防医学は,予防的な医療です.
    • 公衆衛生は公衆衛生である.

    背景:

    • 現在のガイドラインでは,脂質治療の目標を達成することを強調しています.
    • 異常な血脂 (ABL) の管理は複雑で,多様な医療専門家の専門知識が必要です.
    • ABLのための学際的なケースマネジメントモデルが確立されています.

    研究 の 目的:

    • 異常な血脂の管理のための協力的,学際的なアプローチを記述する.
    • 総合的なABL管理の構成要素を強調する.
    • このアプローチが心血管と脳血管の健康に与える影響を強調するためです.

    主な方法:

    • この研究は,ABL.の共同ケアモデルを概説しています.
    • このモデルは,一次予防と二次予防の戦略を統合しています.
    • それは,栄養,運動,および薬理学的介入を含み,遵守を強調します.

    主要な成果:

    • 多学問的アプローチは,生涯の介護を網羅しています.
    • それは,ライフスタイルの変更と薬剤療法を含んでいます.
    • このモデルでは,アデファレンスは重要な焦点です.

    結論:

    • ABLに対する多学科的ケースマネジメントのアプローチの実施が推奨されます.
    • この包括的な戦略は,患者の遵守と結果を改善することを目的としています.
    • このアプローチは,心血管および脳血管疾患および死亡率を減らすことが期待されています.